Literature DB >> 33907603

Cross-sectional associations between cognition and mobility in Parkinson's disease.

Nariana Mattos Figueiredo Sousa1,2, Roberta Correa Macedo1, Sonia Maria Dozzi Brucki2.   

Abstract

Cross-sectional studies show an association of decline in mental flexibility and inhibitory control with reduced gait speed and falls, as well as divided attention deficit and difficulty in initiating gait.
OBJECTIVE: To investigate the relationships between cognitive function and gait performance in patients with Parkinson's disease (PD) who participated in a hospital neurorehabilitation program.
METHODS: A total of 107 patients (79 males, 28 females; mean age 61.00±8.2 years; mean schooling 11.7±4.1 years) with idiopathic PD (mean disease duration 5.5±4.1 years) were recruited for this study. Among them, 78.50% were in stages I and II of the Hoehn & Yahr Scale. Cognitive functions were evaluated through the Digit Span test, Trail Making Test, and Addenbrooke's Cognitive Examination III. Motor function was assessed with the 10-Meter Walk Test, the short version of the Balance Evaluation Systems Test (Mini-BESTest), and the Timed Up and Go Test.
RESULTS: Balance skills were significantly correlated with global cognition and specific domains, including divided attention, verbal fluency, and visuospatial function. Functional mobility showed a significant association with all cognitive tests, except for the number of errors on TMT-A. Gait speed presented a significant correlation with global cognition scores, memory, and attention, including divided attention.
CONCLUSIONS: These findings might help early identification of cognitive deficits or motor dysfunctions in PD patients who may benefit from rehabilitation strategies, as well as facilitate fall risk assessments and strategies to prevent falls. Future prospective studies are needed to investigate the effects of cognitive training on motor performance, since the difficulty in motor rehabilitation may be more related to cognitive loss than to motor damage.

Entities:  

Keywords:  Parkinson’s disease; balance; cognitive impairment; executive functions; gait

Year:  2021        PMID: 33907603      PMCID: PMC8049584          DOI: 10.1590/1980-57642021dn15-010011

Source DB:  PubMed          Journal:  Dement Neuropsychol        ISSN: 1980-5764


INTRODUCTION

Parkinson’s disease (PD) is the second most common neurodegenerative disease, which has cognitive impairment as a prevalent and debilitating non-motor symptom. Non-motor symptoms, such as disturbances of the autonomic nervous system, sleep disorders, depression, and cognitive and neuropsychiatric disorders, can precede motor symptoms or appear throughout the disease, impacting the functional independence of the patient. , Cross-sectional and longitudinal studies – have reported that gait changes may be associated with cognitive impairment, particularly executive functions. Additional investigations have also revealed that slow gait speed predicted cognitive impairment and dementia. However, some studies have suggested that cognitive impairment preceded gait changes. , Studies that correlated the performance on the Montreal Cognitive Assessment (MoCA) with motor tests have found a significant association with dexterity and mobility evaluated through the Purdue Pegboard Test and the Timed Up and Go Test (TUG). Furthermore, although no correlation was found between the tremor dominant subtype and cognitive impairment, the postural instability/gait difficulty (PIGD) subtype showed an association with lower performance on cognitive tests. – Associations between gait and cognition in PD indicate an influence of attention and executive functions on the gait pace and variability. Another study argues whether the impact of cognition on gait performance can be so specific that data collected by wearable devices can contribute to differentiating dementia subtypes. Consistent findings have shown the limited ability of this population to cope with complex tasks that require cognitive demands, namely, recognizing and avoiding obstacles, dividing attention while walking. The ability to plan and monitor gait adequately while dealing with cognitive overload, as well as when performing dual-tasking (DT), is impaired in this population. – Carrying out two tasks simultaneously is difficult for these individuals. Executive function deficit, mainly inhibitory control and mental flexibility, has been associated with gait impairment and freezing of gait (FOG). , , Another study revealed that gait and balance are related to specific cognitive skills, suggesting similar cerebral cortical circuitry for mobility and cognitive function. Cognitive control is essential for gait; cognitive issues are risk factors for poor gait performance, especially falls, consequently limiting the community participation in daily activities. Balance skills were significantly correlated with the ability to divide attention and the visuospatial ability in a recent study conducted by these authors. In addition, several investigations have reported that gait performance, risk of falling, freezing, and PD stage were strongly and significantly associated with DT. , Thus, the present study aimed to examine the association between cognitive ability, including global and specific cognitive functions (i.e., executive function, visuospatial ability, attention, language, and memory), and gait performance in PD patients. In this study, the characteristics of the sample assessed, that is, a homogeneous group as to cognitive profile (patients with mild cognitive impairment), as well as the sample size, contributed to the accuracy of the analyses.

METHODS

Participants

This is a cross-sectional study of 107 patients diagnosed with PD, according to the UK Brain Bank criteria. The subjects were part of an outpatient neurorehabilitation program at the SARAH Network of Rehabilitation Hospitals. The inclusion criteria were: idiopathic PD patients aged over 50 years, more than 4 years of schooling, no psychiatric disorders before the PD diagnosis, as well as no history of substance use and abuse, absence of behavioral, motor, and/or sensory changes that may interfere with the performance of the cognitive tests (patients evaluated in the ON state, with no motor fluctuation during the assessment). Patients with moderate or severe depressive symptoms (Beck Depression Inventory — BDI≥20), Hoehn and Yahr Scale (H&Y) stage IV, and dementia, according to the Movement Disorder Society guidelines, were excluded. All participants signed the informed consent form. The local ethics committee approved this study.

Cognitive evaluation

The patients were evaluated on their global and specific cognitive functions by a neuropsychologist. Digit Span Test (forward and backward) (Wechsler Memory Scale-revised — WMS-R): evaluates the immediate memory capacity and the ability to manipulate information. Trail Making Test (TMT) — A and B: assesses visuomotor speed, selective attention, and mental flexibility. Addenbrooke’s Cognitive Examination-third version (ACE-III): focuses on the global score and subscores (attention/orientation, memory, verbal fluency, visuospatial ability, and language). The maximum score is 100. 10-Meter Walk Test (10MWT): measures walking speed in meters per second while the subject walks 10 meters. The participants were asked to walk at a comfortable pace. Short version of the Balance Evaluation System Test (Mini-BESTest): assesses balance through 14 tasks (anticipatory postural adjustments, reactive postural control, sensory orientation, gait, and dynamic balance). Each task is graded according to the performance on a 3-level ordinal scale (0–2), and the maximum score is 28 points in case of normal performance. Timed Up and Go Test (TUG test): evaluates mobility and balance, calculating the time that a person takes to rise from an armchair, walk three meters, turn around, walk back, and sit down in the chair. In the cognitive TUG, the individual performs the same motor task plus a second motor task or cognitive task concomitantly. In this study, subjects were asked to complete the TUG associated with mathematical tasks requested by the examiner. This test was scored following the same Mini-BESTest scale (0–2), according to the impact of the cognitive task on motor performance.

Data analysis

Statistical Package for the Social Sciences (SPSS) software, version 22.0, was used for data analysis. Descriptive analysis of the study participants was expressed as mean and standard deviation (SD). Pearson’s correlation was applied to assess the association between gait parameters (speed, balance, and functional mobility) and cognitive scores (total and per domains). Some variables (such as age and disease duration and severity) could have skewed these results. A multivariate linear regression analysis was performed to minimize these effects. The probability level was set at 0.05 to determine significance.

RESULTS

Demographic and clinical characteristics

The study included 107 participants (79 male and 28 female). Among them, 84 had mild impairment (stages I–II of H&Y), that is, no patients had less severe disease. PD patients had an average disease duration of 5.5±4.1 years. Table 1 presents their demographic and clinical characteristics.
Table 1

Demographic and clinical characteristics of participants.

n=107Mean±SD/n (%)
Age (years)61.00±8.2
Gender (male/female)79 (73.83)/28 (21.4)
Schooling (years)11.7±4.1
Disease duration (years)5.5±4.1
Hoehn & Yahr Scale
I–II84 (78.50)
III–IV23 (21.49)
BDI6.3±4.8

SD: standard deviation; BDI: Beck Depression Inventory.

SD: standard deviation; BDI: Beck Depression Inventory.

Cognitive and motor performance

Table 2 shows the descriptive data from cognitive and motor performance.
Table 2

Descriptive statistics of cognitive and motor tests.

n=107Mean±SD/n (%)MinimumMaximum
ACE-III/Total score85.07±11.305499
Attention/Orientation16.36±1.781118
Memory19.64±4.73426
Fluency9.97±2.70214
Language25.00±2.171126
Visuospatial14.09±2.60316
Digit Span (forward)5.52±4.4737
Digit Span (backward)3.62±1.0225
TMT-A (s)68.93±29.790189
TMT-A (errors)1.57±1.1904
TMT-B (s)197.40±108.681654
TMT-B (errors)1.19±1.5706
TMT (A–B)−128.5±95.0−1−573
10MWT294±23.9811200
Mini-BESTest22.39±4.23628
TUG 0 or 174 (69.15)
TUG 233 (30.84)

SD: standard deviation; ACE-III: Addenbrooke’s Cognitive Examination; TMT: Trail Making Test; 10MWT: 10-Meter Walk Test; Mini-BESTest: Mini-Balance Evaluation Systems Test; TUG: Timed Up and Go Test.

SD: standard deviation; ACE-III: Addenbrooke’s Cognitive Examination; TMT: Trail Making Test; 10MWT: 10-Meter Walk Test; Mini-BESTest: Mini-Balance Evaluation Systems Test; TUG: Timed Up and Go Test.

Associations between gait and cognition

Significant associations were found between TUG scores and ACE-III total and domain scores, in addition to other neuropsychological tests, except for TMT-A errors (r=−0.0686, p=0.4827). The Mini-BESTest also demonstrated a significant correlation with cognitive measures. Correlations were identified between 10MWT and ACE-III total and memory scores, as well completion time for TMT-A and B (Table 3).
Table 3

Correlations between cognitive and motor variables.

VariablesMini-BESTestTUG10MWT (cm/s)
Total score (ACE-III)r=0.22310.48760.2152
p=0.0209* 0.0000*** 0.0260*
Attention/Orientationr=0.11260.41170.0405
p=0.24810.0000*** 0.6791
Memoryr=0.16580.40940.2857
p=0.08780.0000*** 0.0029**
Fluencyr=0.19100.39060.1673
p=0.0488* 0.0000** 0.0849
Languager=0.08990.26450.1791
p=0.35730.0059** 0.0649
Visuospatialr=0.26420.38740.1835
p=0.0060** 0.0000*** 0.0585
TMT-A (s)r=-0.1981−0.4420−0.2044
p=0.0408* 0.0000*** 0.0347*
TMT-A (errors)r=0.0132−0.0686−0.1297
p=0.89280.48270.1832
TMT-B (s)r=-0.3024−0.4701−0.2291
p=0.0015** 0.0000*** 0.0176*
TMT-B (errors)r=-0.2315−0.33660.1117
p=0.0170* 0.0004*** 0.2542
TMT (B-A)r=0.2633r=0.3689r=0.1815
p=0.0061** p=0.0001*** p=0.0614
Digit Span (forward)r=0.19120.38110.0697
p=0.0486* 0.0001*** 0.4758
Digit Span (backward)r=0.13540.37570.1660
p=0.16450.0001*** 0.0874
BDIr=-0.1007−0.1133−0.0476
p=0.30210.24540.6260
H&Yr=-0.4615−0.3635−0.1766
p=0.0000*** 0.0001*** 0.0689

ACE-III: Addenbrooke’s Cognitive Examination; TMT: Trail Making Test; H&Y: Hoehn & Yahr Scale; BDI: Beck Depression Inventory; Mini-BESTest: Mini-Balance Evaluation Systems Test; TUG: Timed Up and Go Test; 10MWT: 10-Meter Walk Test; r: Pearson’s correlation coefficient.

significant at p<0.05;

significant at p<0.01;

significant at p<0.001.

ACE-III: Addenbrooke’s Cognitive Examination; TMT: Trail Making Test; H&Y: Hoehn & Yahr Scale; BDI: Beck Depression Inventory; Mini-BESTest: Mini-Balance Evaluation Systems Test; TUG: Timed Up and Go Test; 10MWT: 10-Meter Walk Test; r: Pearson’s correlation coefficient. significant at p<0.05; significant at p<0.01; significant at p<0.001. Table 4 reveals that the ACE-III total score was associated with cognitive TUG (β=0.01918, p=0.009), disease severity (evaluated by H&Y), Mini-BESTest (β=−2.74613, p=0.000), and TUG (β=−0.25986, p=0.004).
Table 4

Multiple linear regression analysis.

Dependent variablesACE-TotalDigit Span (forward)Digit Span (backward)TMT-A (s)TMT-B (s)Disease durationH&Y
TUG
β0.019180.00920510.0096998−0.002354−0.0003380.001427−0.25986
p0.009** 0.4630.8960.3490.5620.9150.004**
Mini-BESTest
β−0.067080.14169−0.4036460.007995−0.034887−0.06364−2.74613
p0.1960.1150.4450.6560.4030.000*** 0.000***
10MWT
β−0.465840.7216611.53593−0.010040.05360−0.28694−5.19196
p0.1470.1930.6380.9280.8350.6250.183

ACE: Addenbrooke’s Cognitive Examination; TMT: Trail Making Test; H&Y: Hoehn & Yahr Scale; TUG: Timed Up and Go Test; Mini-BESTest: Mini-Balance Evaluation Systems Test; 10MWT: 10-Meter Walk Test.

significant at p<0.05;

significant at p<0.01;

significant at p<0.001.

ACE: Addenbrooke’s Cognitive Examination; TMT: Trail Making Test; H&Y: Hoehn & Yahr Scale; TUG: Timed Up and Go Test; Mini-BESTest: Mini-Balance Evaluation Systems Test; 10MWT: 10-Meter Walk Test. significant at p<0.05; significant at p<0.01; significant at p<0.001. Secondary analyses were carried out, with the formation of subgroups of aspects such as age and disease duration and severity, since these factors can interfere with the association between gait and cognition variables. The results were the same when correlated with the functional mobility test (TUG). Table 5 indicates a significant correlation between the TUG test and several cognitive tasks, regardless of the sample stratification by the median. Regarding other motor tests (Mini-BESTest and 10MWT), the association was present in younger individuals and those whose disease diagnosis was more recent (shorter disease duration).
Table 5

Pearson’s correlation coefficient. Subgroup: Timed Up and Go Test.

Age (y)Age (y)Disease (y)Disease (y)H&YH&Y
<60≥60<5≥5I–IIIII
ACE (total score)r=0.41890.55440.52760.45040.46900.4472
p=0.0000*** 0.0000*** 0.0000** 0.0010** 0.000*** 0.0250*
Attention/Orientationr=0.25060.57400.43190.43620.38450.2620
p=0.07320.0000*** 0.0008*** 0.0015** 0.0004*** 0.2058
Memoryr=0.40070.42420.39790.46080.39330.4255
p=0.0032** 0.0012** 0.0022** 0.0008*** 0.003** 0.0340*
Fluencyr=0.34670.41330.50490.29930.38100.3805
p=0.0118* 0.0017** 0.0001*** 0.034* 0.0004*** 0.0606
Languager=0.21100.31840.24930.23300.26970.1709
p=0.13330.0178* 0.06140.10350.0143* 0.4140
Visuospatialr=0.32320.41640.50030.20190.35330.4920
p=0.0194* 0.0016** 0.0001*** 0.15960.0111* 0.0125*
TMT-A (s)r=-0.4446−0.4665−0.5077−0.3249−0.38000.4379
p=0.0010** 0.0003*** 0.0001*** 0.0213* 0.0004*** 0.0286*
TMT-A (errors)r=-0.0537−0.0530−0.1221−0.0241−0.05360.2705
p=0.70520.70060.36570.86820.63240.1909
TMT-B (s)r=-0.4506−0.4758−0.5150−0.3576−0.43400.4239
p=0.0008*** 0.0002*** 0.000*** 0.0108* 0.0000*** 0.0347*
TMT-B (errors)r=-0.3098−0.3518−0.4989−0.0754−0.31250.3481
p=0.0254* 0.0091** 0.0001*** 0.60260.0045** 0.0882
TMT (A-B)r=0.35610.35730.41780.27740.37690.2052
p=0.0096** 0.0074** 0.0012** 0.05110.0005*** 0.3251
Digit Span (forward)r=0.41200.38110.35460.43650.33650.4129
p=0.0024** 0.0041** 0.0068** 0.0015** 0.0020** 0.0402*
Digit Span (backward)r=0.37540.37360.41320.29760.30310.4114
p=0.0061** 0.0050** 0.0014** 0.0358* 0.0056* 0.0411*

ACE-III: Addenbrooke’s Cognitive Examination; TMT: Trail Making Test; H&Y: Hoehn & Yahr Scale;

significant at p<0.05;

significant at p<0.01;

significant at p<0.001.

ACE-III: Addenbrooke’s Cognitive Examination; TMT: Trail Making Test; H&Y: Hoehn & Yahr Scale; significant at p<0.05; significant at p<0.01; significant at p<0.001.

DISCUSSION

The present study aimed to determine whether cognitive functions were associated with gait performance, mobility, and balance in idiopathic PD. The findings revealed that motor parameters were significantly related to cognitive skills, especially aspects connected to executive functions and global cognition, evidencing that balance ability and functional mobility were significantly correlated with the ability to divide attention between tasks performed at the same time, as found in similar research. , This interaction has been identified in cognitive tests that assess mental flexibility (TMT-B and TMT B-A), attention (Digit Span forward), working memory (Digit Span backward), and functional mobility (cognitive TUG). The correlation between the simultaneous performance of a functional mobility activity and a mental task increased with cognitive dysfunction. Cognitive decline, especially in executive functions, has been associated with gait disorders and risk of falling. , The association between executive functions and bradykinesia has been reported in individuals with PD, , as well as the correlation between the ability to divide attention between two tasks and balance. A study that researched the relationship between cognition, emotion, and motor function found that those who presented higher freezing rates had worse performance on the Wisconsin Card Sorting Test, TMT-A, and Rey Auditory Verbal Learning Test, indicating an association with tests of executive functions and attention/processing speed. A previous investigation showed a correlation between a functional mobility motor test (TUG) and cognition. However, no correlation between cognitive variables and gait speed test was found. After increasing the sample, the 10MWT also demonstrated a significant association with some cognitive variables, suggesting that impaired cognitive function might be related to slower gait speed. TUG continued to be the motor test with the best correlation, followed by the Mini-BESTest. As real-world activities usually involve the combination of motor and cognitive tasks, the performance of the TUG test with a cognitive task has been chosen as a more sensitive outcome measure to predict the risk of falling. Thus, the cognitive TUG test has been recommended as an essential outcome measure to evaluate mobility and risk of falling. Moreover, a retrospective cohort study of individuals with PD investigated the impact of adding a task (manual or cognitive) to the TUG test and concluded that it increases the responsiveness of the test in detecting the risk of falling. Therefore, the role played by attention skills in safety, effectiveness, and independence during the performance of motor tasks is evident, especially when multiple stimuli are competing with this activity, which is usual when it comes to community participation. The present results are consistent with a previous cross-sectional study that also reports an association between changes in gait and cognitive decline. , Finally, this research offers some ideas for the assessment, referral, and holistic treatment of PD patients, since the individual who seeks the medical or physical therapy service with gait and mobility deficits may be eligible for a cognitive assessment and personalized rehabilitation program that covers not only the motor aspects. This interdisciplinary and biopsychosocial approach is also acknowledged in two recent meta-analyses. , This study has several strengths: neuropsychological evaluation with standardized cognitive measures, patients with similar cognitive characteristics (mild cognitive impairment), motor assessment through a quantitative tool. It also has some limitations, such as evaluating only gait speed, without other measures like cadence and single or double support time. In conclusion, the present findings suggest the critical role played by divided attention, visuospatial ability, and mental flexibility in the gait of PD patients. Thus, individuals with impaired mobility should not only be evaluated by a neuropsychologist but also have a personalized rehabilitation plan involving motor and cognitive training, when possible.
  32 in total

1.  Predictors of dementia in Parkinson's disease; findings from a 5-year prospective study using the SCOPA-COG.

Authors:  Kangdi Zhu; Jacobus J van Hilten; Johan Marinus
Journal:  Parkinsonism Relat Disord       Date:  2014-06-26       Impact factor: 4.891

2.  Physiotherapy for freezing of gait in Parkinson's disease: a systematic review and meta-analysis.

Authors:  K J Miller; D Suárez-Iglesias; M Seijo-Martínez; C Ayán
Journal:  Rev Neurol       Date:  2020-03-01       Impact factor: 0.870

3.  Antisaccade errors reveal cognitive control deficits in Parkinson's disease with freezing of gait.

Authors:  Courtney C Walton; Claire O'Callaghan; Julie M Hall; Moran Gilat; Loren Mowszowski; Sharon L Naismith; James R Burrell; James M Shine; Simon J G Lewis
Journal:  J Neurol       Date:  2015-10-13       Impact factor: 4.849

4.  Do cognition and other non-motor symptoms decline similarly among patients with Parkinson's disease motor subtypes? Findings from a 5-year prospective study.

Authors:  L Arie; Talia Herman; S Shema-Shiratzky; N Giladi; J M Hausdorff
Journal:  J Neurol       Date:  2017-09-06       Impact factor: 4.849

Review 5.  Prevalence and clinical aspects of mild cognitive impairment in Parkinson's disease: A meta-analysis.

Authors:  Chiara Baiano; Paolo Barone; Luigi Trojano; Gabriella Santangelo
Journal:  Mov Disord       Date:  2019-11-19       Impact factor: 10.338

6.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

7.  Cognitive associations with comprehensive gait and static balance measures in Parkinson's disease.

Authors:  Rosie Morris; Douglas N Martini; Katrijn Smulders; Valerie E Kelly; Cyrus P Zabetian; Kathleen Poston; Amie Hiller; Kathryn A Chung; Laurice Yang; Shu-Ching Hu; Karen L Edwards; Brenna Cholerton; Thomas J Grabowski; Thomas J Montine; Joseph F Quinn; Fay Horak
Journal:  Parkinsonism Relat Disord       Date:  2019-07-04       Impact factor: 4.891

8.  Motor dual-tasking deficits predict falls in Parkinson's disease: A prospective study.

Authors:  Sebastian Heinzel; Mirjam Maechtel; Sandra E Hasmann; Markus A Hobert; Tanja Heger; Daniela Berg; Walter Maetzler
Journal:  Parkinsonism Relat Disord       Date:  2016-03-14       Impact factor: 4.891

9.  Dual task performance in Parkinson's disease: a sensitive predictor of impairment and disability.

Authors:  Rebecca L Fuller; Elizabeth P Van Winkle; Karen E Anderson; Ann L Gruber-Baldini; Terra Hill; Cris Zampieri; William J Weiner; Lisa M Shulman
Journal:  Parkinsonism Relat Disord       Date:  2012-12-21       Impact factor: 4.891

10.  The effects of dual-task in patients with Parkinson's disease performing cognitive-motor paradigms.

Authors:  Chang Hsiu-Chen; Chen Chiung-Chu; Liaw Jiunn-Woei; Chiou Wei-Da; Weng Yi-Hsin; Chang Ya-Ju; Lu Chin-Song
Journal:  J Clin Neurosci       Date:  2020-01-14       Impact factor: 1.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.